Cargando…
Rituximab-conjugated, doxorubicin-loaded microbubbles as a theranostic modality in B-cell lymphoma
This study evaluated rituximab-conjugated, doxorubicin-loaded microbubbles (RDMs) in combination with ultrasound as molecular imaging agents for early diagnosis of B cell lymphomas, and as a targeted drug delivery system. Rituximab, a monoclonal CD20 antibody, was attached to the surfaces of doxorub...
Autores principales: | Zhou, Shoubing, Zhang, Xiu, Wang, Cailian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354869/ https://www.ncbi.nlm.nih.gov/pubmed/27902473 http://dx.doi.org/10.18632/oncotarget.13587 |
Ejemplares similares
-
Retraction note: Rituximab-conjugated, doxorubicin-loaded microbubbles as a theranostic modality in B-cell lymphoma
por: Zhou, Shoubing, et al.
Publicado: (2017) -
Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells
por: Zhou, Shoubing, et al.
Publicado: (2017) -
Microbubble–liposome conjugate: Payload evaluation of potential theranostic vehicle
por: Malik, Ritu, et al.
Publicado: (2016) -
Theranostic mRNA-loaded Microbubbles in the Lymphatics of Dogs: Implications for Drug Delivery
por: Dewitte, Heleen, et al.
Publicado: (2015) -
Theranostic Oxygen Delivery Using Ultrasound and Microbubbles
por: Kwan, James J., et al.
Publicado: (2012)